Home › Eosinophilic Esophagitis › NCT05199532

Eosinophilic Gastrointestinal Disorders Registry

Who can join

Ages 1 to 25 · All sexes

Inclusion Criteria:

* Patients with an established diagnosis of an EGID, based on pathology findings from an endoscopy or colonoscopy with biopsies.
* Patients suspected of having an EGID and undergoing endoscopic evaluation for further assessment

Exclusion Criteria:

* Patients who do not consent to participate

About the study

The purpose of this study is to learn more about Eosinophilic Gastrointestinal Disorders (EGIDs). With this registry we hope to find out more about the symptoms that patients have during their treatment, the quality of life they have with the diagnosis, what the disease looks like throughout the different treatment methods, and if there is a connection between EGIDs and connective tissue disorders.

The goal of this study is to be able to better understand EGIDs and use information gained from all the information collected on this study for more precise treatments in the future. We want to create a large collection of samples, called a biorepository, to learn the most about EGIDs as possible. When the samples are collected, which will occur at procedures directed by your child's doctor as part of their standard of care, they will be stored for an unlimited amount of time to perform experiments on these samples and to gather information about EGIDs

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago · Participants: 500 · Started: Dec 18, 2020

Contact the study team

• Angela Anthony · Phone: 312-227-4559
• Mary Riordan · Phone: 312-227-4558

Official record on ClinicalTrials.gov — NCT05199532

Locations in the U.S.

Conditions

• Eosinophilic Esophagitis

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.